These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29334539)

  • 1. Gelatin-Based Hemostatic Agents: Histopathologic Differences.
    Wolkow N; Jakobiec FA; Yoon MK
    Ophthalmic Plast Reconstr Surg; 2018; 34(5):452-455. PubMed ID: 29334539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
    Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
    Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hemostatic agents based on gelatin-microbial transglutaminase mix.
    Lv F; Cong X; Tang W; Han Y; Tang Y; Liu Y; Su L; Liu M; Jin M; Yi Z
    Sci China Life Sci; 2017 Apr; 60(4):397-403. PubMed ID: 28321657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
    David G; Lim S; Gunnarsson C; Kocharian R; Roy S
    J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What happens to hemostatic agents in contact with urine? An in vitro study.
    Uribe CA; Eichel L; Khonsari S; Finley DS; Basillote J; Park HK; Li CC; Abdelshehid C; Lee DI; McDougall EM; Clayman RV
    J Endourol; 2005 Apr; 19(3):312-7. PubMed ID: 15865520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.
    Obermair H; Janda M; Obermair A
    Acta Obstet Gynecol Scand; 2016 Sep; 95(9):1008-14. PubMed ID: 27199208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable gelatin used as hemostatic agent to stop pedicle bleeding in long deformity surgical procedures: does it embolize?
    Kuhns CA; Cook CR; Dodam JR; Leach SB; Kuroki K; Jenkins TJ; Tallmage AM; Hoernschemeyer DG
    Spine (Phila Pa 1976); 2015 Feb; 40(4):218-23. PubMed ID: 25494314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
    Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
    J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative anaphylaxis secondary to intraosseous gelatin administration.
    Luhmann SJ; Sucato DJ; Bacharier L; Ellis A; Woerz C
    J Pediatr Orthop; 2013; 33(5):e58-60. PubMed ID: 23752162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a surgeon-prepared gelatin hemostatic agent compared with FloSeal for hemostasis in laparoscopic partial nephrectomy.
    Guzzo TJ; Pollock RA; Forney A; Aggarwal P; Matlaga BR; Allaf ME
    J Endourol; 2009 Feb; 23(2):279-82. PubMed ID: 19196066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Experimental Study of Histopathologic Effects of Hemostatic Agents Used in Spinal Surgery.
    Altun I
    World Neurosurg; 2016 Jun; 90():147-153. PubMed ID: 26898493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
    Gazzeri R; Galarza M; Alfier A
    Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
    Makhija D; Rock M; Xiong Y; Epstein JD; Arnold MR; Lattouf OM; Calcaterra D
    J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
    Landi A; Gregori F; Marotta N; Delfini R
    J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
    Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
    Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic properties of in situ gels composed of hydrophobically modified biopolymers.
    Mizuta R; Taguchi T
    J Biomater Appl; 2018 Aug; 33(2):315-323. PubMed ID: 30096998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic action of polyurethane foam with 55% polyethylene glycol compared to collagen and gelatin.
    Broekema FI; van Oeveren W; Boerendonk A; Sharma PK; Bos RR
    Biomed Mater Eng; 2016 Aug; 27(2-3):149-59. PubMed ID: 27567771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for systematically evaluating the hemostatic ability of hydrogels in vitro.
    Luo J; Lin L; Liao N; Zhang K; Liu C; Sun Y
    Biomed Mater Eng; 2017; 28(6):703-710. PubMed ID: 29171971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Morphologic and Cytochemical Staining Properties of Exogenous Materials Mimicking Fungal Organisms Encountered in Skin Biopsies.
    Lindsey M; Vishal S; Gardner JM; Shalin SC
    Am J Dermatopathol; 2021 Oct; 43(10):679-687. PubMed ID: 34546986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery.
    Danker W; Kelkar SS; Marston XL; Aggarwal J; Johnston SS
    J Comp Eff Res; 2022 Dec; 11(17):1231-1240. PubMed ID: 36306241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.